BioCentriq is a full service CDMO. We offer product development and clinical production for cell and gene therapies. BioCentriq was founded in 2019 and launched our pilot development plant at the same time. In October of 2020 we completed the validation of our GMP center and opened the doors for clinical manufacturing.
Our mission is to accelerate the advancement of cell and gene therapies by improving the efficiency and effectiveness of manufacturing processes and technologies. To support that mission, we also offer custom and standard workforce development programs to help close the skills gap that exists in the industry today.